BCA
XLRN

Benchmark Capital Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History

Benchmark Capital Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,500
Closed -$391K – 135
2016
Q2 		$391K Hold
11,500
– – 0.32% 74
2016
Q1 		$303K Buy
11,500
+5,000
+77% +$132K 0.27% 85
2015
Q4 		$317K Buy
+6,500
New +$317K 0.27% 77